Cargando…

New Direct Oral Anticoagulants (DOAC) and Their Use Today

The ideal anticoagulant is oral, has a wide therapeutic range, predictable pharmacokinetics and pharmacodynamics, a rapid onset of action, an available antidote, minimal side effects and minimal interactions with other drugs or food. With the development of the novel direct oral anticoagulants (DOAC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarb, Heike, Tsakiris, Dimitrios A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851208/ https://www.ncbi.nlm.nih.gov/pubmed/29563447 http://dx.doi.org/10.3390/dj4010005

Ejemplares similares

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review
por: Sunkara, Tagore, et al.
Publicado: (2016)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis
por: Jarboe, Lindsey, et al.
Publicado: (2022)

Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
por: Ferri, Nicola, et al.
Publicado: (2022)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine
por: Harenberg, Job, et al.
Publicado: (2021)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
por: van Gorp, Rick H., et al.
Publicado: (2015)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
por: Baker, Steven Andrew, et al.
Publicado: (2021)

The Effect of Direct Oral Anticoagulant Therapy (DOACs) on oral surgical procedures: a systematic review
por: Darwish, Ghassan
Publicado: (2023)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy
por: Martin Diaz, Claudia, et al.
Publicado: (2021)

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples
por: Linskens, Eleni A., et al.
Publicado: (2022)

Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
por: McFadzean, Isobel Joy, et al.
Publicado: (2023)

Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer’s Disease
por: Grossmann, Klaus
Publicado: (2022)

Can We Improve on the Rapid Assessment of Clinically Relevant Levels of Direct Acting Oral Anticoagulants (DOAC)?
por: Walenga, Jeanine M.
Publicado: (2022)

Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review
por: Sheklabadi, Elahe, et al.
Publicado: (2022)

Peri-Procedural Management of Direct-Acting Oral Anticoagulants (DOACs) in Transcatheter Miniaturized Leadless Pacemaker Implantation
por: Regoli, François Diederik, et al.
Publicado: (2023)

Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?
por: Antoni, Anna, et al.
Publicado: (2022)

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter
por: Farkh, Carine, et al.
Publicado: (2021)

Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol
por: Lupi, Saturnino Marco, et al.
Publicado: (2020)

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms
por: Huenerbein, Karlo, et al.
Publicado: (2020)

Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta‐analysis
por: Shrestha, Dhan B., et al.
Publicado: (2023)

Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS
por: Brückner, Lea, et al.
Publicado: (2021)

Spontaneous rectal sheath bleed while on DOAC anticoagulation
por: de Courcy, Louis, et al.
Publicado: (2023)

DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
por: Langenaeken, Tom, et al.
Publicado: (2023)

Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD)
por: Porter, Kim Maria Frances, et al.
Publicado: (2021)

Treatment with the direct oral anticoagulants (DOACs) Apixaban and Rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD)
por: Porter, Kim, et al.
Publicado: (2021)

Has the introduction of direct oral anticoagulants (DOACs) in England increased emergency admissions for bleeding conditions? A longitudinal ecological study
por: Alfirevic, Ana, et al.
Publicado: (2020)

Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration
por: Örd, Lenna, et al.
Publicado: (2022)

Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants
por: Papageorgiou, Loula, et al.
Publicado: (2023)

Optimization of DOAC management services in a centralized anticoagulation clinic
por: Sylvester, Katelyn W., et al.
Publicado: (2022)

Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients?
por: Leer-Salvesen, Sunniva, et al.
Publicado: (2020)

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis
por: Martini, Andrea, et al.
Publicado: (2021)

Treatment of venous thromboembolism in cancer patients: a systematic review and meta-analysis on the efficacy and safety of different direct oral anticoagulants (DOACs)
por: Song, Xiaojun, et al.
Publicado: (2021)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_460oslfa45u4ntk8nfk69spj43